Transient limb ischemia induces remote preconditioning in liver among rats: the protective role of heme oxygenase-1. 2006

I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.

BACKGROUND We have reported the protective role of heme oxygenase-1 (HO-1) in the mechanism of hypoxic preconditioning. We wish to investigate the role of HO-1 in remote preconditioning (RP) against hepatic ischemia/reperfusion (I/R) injury in rats. METHODS The remote preconditioning was produced by four cycles of 10-min ischemia-reperfusion of the hind limb of rats. Partial hepatic ischemia was produced in the left lobes for 45 min followed by 240 min of reperfusion. Zinc-protoporphyrin IX (ZnPP), a specific inhibitor of HO enzymatic activity, was intra-peritoneally injected 1 hr before the ischemia-reperfusion injury in separate groups of RP rats. Serum alanine transaminase (ALT) levels, expression of hepatic HO-1 protein and mRNA, immunohistochemical staining and HO enzymatic activity were measured. RESULTS HO-1 was induced in the livers of rats 4 hr after the RP stimuli, and the overexpression persisted for 24 hr. Immunohistochemical staining demonstrated induction of HO-1 in the hepatocytes. The peripheral lymphocytes did not express HO-1 after RP. RP diminished the elevation of serum ALT levels 4 hr after I/R injury (283.7+/-167.4 U L) when compared with controls (1297.7+/-729.3 U L) and RP+ ZnPP pretreated groups (1429.9+/-750.9 U L). The heme oxygenase activity in treated rats also correlated these results (286.8+/-34.3 pmol mg protein hr for the RP group, 156.3+/-27.5 pmol mg protein hr for the RP+ ZnPP pretreated group, and 170.6+/-19.4 pmol mg protein hr for the control group, 144.8+/-7.8 pmol mg protein hr for the control+ ZnPP pretreated group). CONCLUSIONS Our results indicated that the induction of HO-1 in remote preconditioning played a protective role against hepatic I/R injury.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D005260 Female Females
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
September 2014, The Journal of surgical research,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
June 2003, Circulation,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
December 2002, Circulation,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
June 2019, Medical molecular morphology,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
January 2014, PloS one,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
October 2004, Antioxidants & redox signaling,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
December 2010, Central nervous system agents in medicinal chemistry,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
May 2011, The Journal of surgical research,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
November 2010, Antioxidants & redox signaling,
I-Rue Lai, and King-Jen Chang, and Chau-Fong Chen, and Hsiu-Wen Tsai
January 2007, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!